57 results
8-K
EX-99.1
BTAX
Biostax Corp.
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
with the Company.
The Company believes that the management changes will not affect its ability to realize its strategic goals, including … the strategic, scientific, and operational experience capable of delivering the company’s future goals and milestones in a timely and effective manner
8-K
EX-10.1
BTAX
Biostax Corp.
27 Jul 20
Departure of Directors or Certain Officers
3:07pm
and restate these terms in a more comprehensive agreement that includes milestones, goals, and other specifics for the benefit of both parties within thirty … and goals. A five-year warrant to purchase up to three percent (3%) of Immune’s outstanding shares following issuance of shares from note conversions
8-K
EX-99.1
BTAX
Biostax Corp.
20 Jan 15
Immune Therapeutics, Inc. Announces Appointment of New Director and Acceptance of Election by Director
12:00am
the Immune Therapeutics team has put together, I am very excited to both help the business fulfill its goals and be a part of its growth and success going